Investors

Fluidigm Corporation (NASDAQ: FLDM) is a leading innovator in the single-cell biology (genomics and proteomics) market.  We simplify the complex quest to understand and apply biology by developing and manufacturing analytical and preparatory systems for single-cell biology and production genomics markets that significantly streamline experimental workflows, increase throughput, and reduce costs, while providing excellent data quality.  Our products are based on proprietary microfluidics and multi-parameter mass cytometry technology and are sold to academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide.

Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures..